{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:01:18Z","timestamp":1775250078976,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00896","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T06:36:56Z","timestamp":1556260616000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection"],"prefix":"10.3389","volume":"10","author":[{"given":"Hyejon","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok Ryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bora","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Zelmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen A.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel M.","family":"Dockrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Nae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"B1","year":"2017","journal-title":"Global Tuberculosis Report 2017."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3201\/eid2111.141894","article-title":"Achievements in and challenges of tuberculosis control in South Korea","volume":"21","author":"Kim","year":"2015","journal-title":"Emerg Infect Dis."},{"key":"B4","first-page":"27","article-title":"The seventh nationwide tuberculosis prevalence survey in Korea, 1995","volume":"2","author":"Hong","year":"1998","journal-title":"Int J Tuberc Lung Dis."},{"key":"B5","unstructured":"Tuberculosis2007"},{"key":"B6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jctube.2018.04.006","article-title":"Tuberculosis prevention and care in Korea: evolution of policy and practice","volume":"11","author":"Go","year":"2018","journal-title":"J Clin Tuberc Other Mycobact Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4046\/trd.2013.74.3.104","article-title":"Increased tuberculosis burden due to demographic transition in Korea from 2001 to 2010","volume":"74","author":"Park","year":"2013","journal-title":"Tuberc Respir Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B9","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3389\/fimmu.2017.01203","article-title":"TBVAC2020: advancing tuberculosis vaccines from discovery to clinical development","volume":"8","author":"Kaufmann","year":"2017","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/s41598-017-02116-1","article-title":"Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis","volume":"7","author":"Jensen","year":"2017","journal-title":"Sci Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e00142","DOI":"10.1128\/CVI.00142-17","article-title":"The cross-species mycobacterial growth inhibition assay (MGIA) Project, 2010-2014","volume":"24","author":"Brennan","year":"2017","journal-title":"Clin Vaccine Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1016\/j.vaccine.2016.07.058","article-title":"In vitro mycobacterial growth inhibition assays: a tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy","volume":"34","author":"Tanner","year":"2016","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/infdis\/jit647","article-title":"Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination","volume":"209","author":"Harris","year":"2014","journal-title":"J Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1128\/CVI.00427-13","article-title":"Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG","volume":"20","author":"Fletcher","year":"2013","journal-title":"Clin Vaccine Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1038\/s41598-019-41008-4","article-title":"Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells","volume":"9","author":"Prabowo","year":"2019","journal-title":"Sci Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1172\/Jci97508","article-title":"Mycobacterial growth inhibition is associated with trained innate immunity","volume":"128","author":"Joosten","year":"2018","journal-title":"J Clin Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1128\/CVI.00067-09","article-title":"Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis","volume":"16","author":"Parra","year":"2009","journal-title":"Clin Vaccine Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1128\/IAI.72.11.6401-6407.2004","article-title":"Novel human in vitro system for evaluating antimycobacterial vaccines","volume":"72","author":"Kampmann","year":"2004","journal-title":"Infect Immun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1128\/Cdli.9.4.901-907.2002","article-title":"Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis","volume":"9","author":"Cheon","year":"2002","journal-title":"Clin Diagn Lab Immun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S257","DOI":"10.1086\/313887","article-title":"In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guerin","volume":"30","author":"Worku","year":"2000","journal-title":"Clin Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1101\/020560","article-title":"Ex vivo mycobacterial growth inhibition assay (MGIA) for tuberculosis vaccine testing - a protocol for mouse splenocytes","author":"Zelmer","year":"2015","journal-title":"BioRxiv"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2019.01.006","article-title":"Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells","author":"Tanner","year":"2019","journal-title":"J Immunol Methods."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14480","DOI":"10.1038\/s41598-018-32755-x","article-title":"Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection","volume":"8","author":"O'Shea","year":"2018","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"43478","DOI":"10.1038\/srep43478","article-title":"The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays","volume":"7","author":"Tanner","year":"2017","journal-title":"Sci Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1086\/319679","article-title":"A whole blood bactericidal assay for tuberculosis","volume":"183","author":"Wallis","year":"2001","journal-title":"J Infect Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1086\/344359","article-title":"Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity","volume":"186","author":"Hoft","year":"2002","journal-title":"J Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1086\/315766","article-title":"Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria","volume":"182","author":"Kampmann","year":"2000","journal-title":"J Infect Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.1016\/j.vaccine.2016.09.002","article-title":"Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants","volume":"34","author":"Smith","year":"2016","journal-title":"Vaccine."},{"key":"B30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S2213-2600(18)30077-8","article-title":"Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial","volume":"6","author":"Penn-Nicholson","year":"2018","journal-title":"Lancet Respir Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41541-018-0057-5","article-title":"The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial","volume":"3","author":"Coler","year":"2018","journal-title":"NPJ Vaccines."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.vaccine.2016.03.029","article-title":"Pulmonary immunity and durable protection induced by the ID93\/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K","volume":"34","author":"Cha","year":"2016","journal-title":"Vaccine."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.4049\/jimmunol.180.5.3569","article-title":"Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles","volume":"180","author":"Soares","year":"2008","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1177\/0962280215601873","article-title":"A new approach to categorising continuous variables in prediction models: proposal and validation","volume":"26","author":"Barrio","year":"2017","journal-title":"Stat Methods Med Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of serial QuantiFERON testing to measure acquisition of Mycobacterium tuberculosis Infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/infdis\/jiw141","article-title":"Association of human antibodies to arabinomannan with enhanced mycobacterial opsonophagocytosis and intracellular growth reduction","volume":"214","author":"Chen","year":"2016","journal-title":"J Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.it.2011.10.003","article-title":"Neutrophils in tuberculosis: friend or foe?","volume":"33","author":"Lowe","year":"2012","journal-title":"Trends Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1128\/IAI.73.10.6711-6720.2005","article-title":"Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies","volume":"73","author":"de","year":"2005","journal-title":"Infect Immun."},{"key":"B39","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.4049\/jimmunol.144.7.2771","article-title":"Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3","volume":"144","author":"Schlesinger","year":"1990","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1086\/597069","article-title":"Population differences in immune responses to bacille calmette-guerin vaccination in infancy","volume":"199","author":"Lalor","year":"2009","journal-title":"J Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T02:31:27Z","timestamp":1694831487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2019.00896"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00896","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]},"article-number":"896"}}